Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Uridine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 17,786Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biolinerx Receives USPTO Notice For GLIX1 Cancer Treatment
    Biolinerx Receives USPTO Notice For GLIX1 Cancer Treatment

    17 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biolinerx-announces-receipt-of-uspto-notice-of-allowance-for-key-patent-covering-glix1-for-treating-a-broad-range-of-cancer-types-302616834.html

    PR NEWSWIRE
    17 Nov 2025
    Share Share
    Xinxiang Tuoxin Biochemical Co. Ltd on USFDA import alert
    Xinxiang Tuoxin Biochemical Co. Ltd on USFDA import alert

    06 Apr 2016

    // FDA

    http://www.accessdata.fda.gov/cms_ia/importalert_189.html

    FDA
    06 Apr 2016
    Share Share
    Wellstat Therap's Vistogard (Uridine triacetate) approved in US for management of fluorouracil toxicity
    Wellstat Therap's Vistogard (Uridine triacetate) approved in US for management of fluorouracil toxicity

    11 Dec 2015

    // FDA

    https://www.pharmacompass.com/pdf/news/wellstat-theraps-vistogard-uridine-triacetate-approved-in-us-for-management-of-fluorouracil-toxicity-1449908564.pdf

    FDA
    11 Dec 2015
    Share Share